Acquiring Company
Galmed Pharmaceuticals Ltd
Acquired Company
Colospan Ltd
Description
Galmed Pharmaceuticals has announced its acquisition of Colospan, aimed at creating a GI-focused platform. Colospan will become a wholly owned subsidiary, enhancing Galmed's capabilities with its innovative medical device technologies. The acquisition is expected to close in Q2 2026 and has been unanimously approved by both companies' boards.
Fundz sees it the moment Galmed Pharmaceuticals Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Colospan Ltd?
Colospan Ltd was acquired by Galmed Pharmaceuticals Ltd, based in Tel Aviv District. The deal was reported on June 8, 2026. Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing innovative therapies for liver diseases and other conditions. Galmed Pharmaceuticals Ltd is publicly traded (EOCN) and operates in Biotechnology.
When did Galmed Pharmaceuticals Ltd acquire Colospan Ltd?
Galmed Pharmaceuticals Ltd's acquisition of Colospan Ltd was reported on June 8, 2026. Galmed Pharmaceuticals has announced its acquisition of Colospan, aimed at creating a GI-focused platform. Colospan will become a wholly owned subsidiary, enhancing Galmed's capabilities with its innovative medical device technologies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Colospan Ltd do?
Colospan Ltd. is a commercial-stage medical device company specializing in innovative solutions for colorectal surgery complications, particularly addressing anastomotic leaks. It is privately held, operating in Manufacturing, and is based in Raipur.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.